论文部分内容阅读
总部位于美国马萨诸塞州Quincy的Myriant技术公司与Johnson Matthey公司旗下的英国戴维工艺技术(Davy Process Technology,DPT)公司于2011年2月21日签署了谅解备忘录,将使用琥珀酸作为生物衍生原料,来生产丁二醇、四氢呋喃和γ-丁内酯。该谅解备忘录涵盖Myriant和DPT两家公司之间的合作,首先进行非独家测试和批准Myriant的产品琥珀酸作为戴维过程的原料,第二将独家联合开发使Myriant生物琥珀酸技术与DPT丁二醇技术相结合,以最大限度地减少琥珀酸的回收和净化成本,用于生产生物丁二醇。
Myriant Technologies, a Quincy, Mass., Company, and Davy Process Technology (DPT), a unit of Johnson Matthey, signed a memorandum of understanding on February 21, 2011 that will use succinic acid as a bio-derived raw material, To produce butanediol, tetrahydrofuran and γ-butyrolactone. The Memorandum of Understanding covers the cooperation between Myriant and DPT, first conducting non-exclusive testing and approving Myriant’s product, succinic acid, as the raw material for the process. The second will be the exclusive joint development of the Myriant bio-succinic acid technology with DPT Alcohol technology to minimize the cost of succinic acid recovery and purification for the production of biobutanols.